US BANCORP \DE\ - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$295,000
+2358.3%
7,950
+1186.4%
0.00%
Q2 2022$12,000
-36.8%
618
-13.6%
0.00%
Q1 2022$19,000
+58.3%
715
+29.8%
0.00%
Q4 2021$12,000
+1100.0%
551
+1867.9%
0.00%
Q3 2021$1,000280.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders